Reminder: Clinical Trials for a medication/device that could be the first ever medication specifically designated for treating CVS. New sites have been added. There may be help with travel if there is not a site near you, contact the site nearest you to find out if you qualify.
The CVSA and Alexza Pharmaceuticals would like to inform the CVSA membership of a clinical trial that has recently begun for adult patients with CVS.
The title of the study is: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF STACCATO® GRANISETRON (AZ-010) FOR THE ACUTE TREATMENT OF MODERATE TO SEVERE CYCLIC VOMITING SYNDROME.